We are a pre-clinical biotech company, pioneering a paradigm shift in the modification of the innate immune system to effectively combat severe diseases.
Our patented novel treatment uses ex-vivo stem cells gene-editing technique to minimize the collateral damage caused by the immune system as a result of its activity. By doing so, we expect to attenuate the progression of these diseases significantly.
We focus first on treating Pulmonary Arterial Hypertension (PAH), a rare, devastating cardiovascular disease which, if left untreated, leads to heart failure and death.
There is currently no cure for this disease, and the primary aims of the current treatments are to improve symptoms and increase exercise tolerance.
Our concept has already been proven to work in animal models of Alzheimer's Disease, Multiple Sclerosis, cardiovascular diseases, and more.
Company Details
- Employees
- 3
- Address
- Binyamina, Israel 3050000, Il
- Industry
- Biotechnology
- Website
- https://www.lempo-tx.com/
- Keywords
- Gene Editing, CRISPR, Myeloperoxidase, Pulmonary Arterial Hypertension, PAH, Stem Cells, MPO, NETosis, Immune.
- HQ
- Binyamina, Israel
Lempo Therapeutics Ltd. Questions
Lempo Therapeutics Ltd.'s website is https://www.lempo-tx.com/
Lempo Therapeutics Ltd.'s LinkedIn profile is https://il.linkedin.com/company/lempo-therapeutics
Lempo Therapeutics Ltd. has
3 employees.
View email and phone details for 3
employees at Lempo Therapeutics Ltd..
Lempo Therapeutics Ltd.'s industry is
Biotechnology
Lempo Therapeutics Ltd.'s top competitors are
Alma Lasers,
Bio-Lead Ltd,
Identt Bio,
Play Space,
Myelin Tech Space Llc.,
Leminda Ai,
Dataflipper,
Freshbiz Global Ltd,,
Granalix Bio Technologies Ltd.,
Play Space Services.
Lempo Therapeutics Ltd.'s categories are Biotechnology
